Chronic modulation of endocannabinoid receptors does not impact hyperactivity, risk behavior, and working memory in an animal model of attention-deficit/hyperactivity disorder
Pharmacology Biochemistry and Behavior · 2025
DOI: 10.1016/j.pbb.2025.174059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Daniel Bussinger de Souza Penna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Fluminense Federal University, Niteroi, Brazil. Electr…. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Memory, Short-Term, Risk-Taking, Receptor, Cannabinoid, CB1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by impairments in executive functions, including behavioral inhibition and working memory. The most widely accepted neurobiological explanation for ADHD is related to dopaminergic hypofunction. The dopaminergic system is modulated by endocannabinoid ligands, primarily through the action of cannabinoid receptors type 1 and 2 (CB1R and CB2R) within frontostriatal circuits. Spontaneously hypertensive rats (SHR) are a widely used animal model for studying the neurobiology of ADHD. Our recent study demonstrated that acute treatment with synthetic CB1R and CB2R ligands increased hyperactivity and risk-taking behavior in SHR. We now investigate how chronic modulation of these receptors affects hyperactivity, risk-taking behavior, and working memory assessment in SHR. As expected, the SHR exhibited hyperactivity, difficulties in risk assessment, impaired working memory, and increased risk-taking behavior. Notably, females SHR displayed higher levels of locomotion and risk-taking behavior than their male counterparts, regardless of treatment. Chronic modulation of CB1R and CB2R did not lead to significant changes in any of the evaluated behavioral parameters. Further research is needed to understand both the acute and chronic effects of manipulating cannabinoid receptors and endocannabinoids in the context of ADHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Fluminense Federal University, Niteroi, Brazil. Electronic address: dbspenna@id.uff.br.
- Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Fluminense Federal University, Niteroi, Brazil.
- Institute of Biology, Program of Neurosciences, Fluminense Federal University, Niteroi, Brazil.
- Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Fluminense Federal University, Niteroi, Brazil; Institute of Biology, Program of Neurosciences, Fluminense Federal Universit…
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Bussinger de Souza Penna, D., Gumiéro Costa, S., Davis, M. P., da Costa Calaza, K., Dos Santos Rodrigues, A., & Pandolfo, P. (2025). Chronic modulation of endocannabinoid receptors does not impact hyperactivity, risk behavior, and working memory in an animal model of attention-deficit/hyperactivity disorder. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2025.174059
Vancouver
Bussinger de Souza Penna D, Gumiéro Costa S, Davis MP, da Costa Calaza K, Dos Santos Rodrigues A, Pandolfo P. Chronic modulation of endocannabinoid receptors does not impact hyperactivity, risk behavior, and working memory in an animal model of attention-deficit/hyperactivity disorder. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2025.174059
BibTeX
@article{BussingerdeSouzaPenna2025,
author = {Bussinger de Souza Penna, Daniel and Gumiéro Costa, Samara and Davis, Marina Pollis and da Costa Calaza, Karin and Dos Santos Rodrigues, Alexandre and Pandolfo, Pablo},
title = {Chronic modulation of endocannabinoid receptors does not impact hyperactivity, risk behavior, and working memory in an animal model of attention-deficit/hyperactivity disorder},
journal = {Pharmacology Biochemistry and Behavior},
year = {2025},
doi = {10.1016/j.pbb.2025.174059}
}
EUVIMED